Manuscripts and Publications

Filters: First Letter Of Last Name is P  [Clear All Filters]
2006
Turnbull EL, A Lopes R, Jones NA, Cornforth D, Newton P, Aldam D, Pellegrino P, Turner J, Williams I, Wilson CM et al..  2006.  HIV-1 epitope-specific CD8+ T cell responses strongly associated with delayed disease progression cross-recognize epitope variants efficiently.. J Immunol. 176(10):6130-46.
Viani RM, Peralta L, Aldrovandi G, Kapogiannis BG, Mitchell R, Spector SA, Lie YS, Weidler JM, Bates MP, Liu N et al..  2006.  Prevalence of primary HIV-1 drug resistance among recently infected adolescents: a multicenter adolescent medicine trials network for HIV/AIDS interventions study.. J Infect Dis. 194(11):1505-9.
2007
Sill AM, Kreisel K, Deeds BGriffin, Wilson CM, Constantine NT, Peralta L.  2007.  Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections.. J Clin Lab Anal. 21(1):40-5.
Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F et al..  2007.  Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.. J Virol. 81(4):1619-31.
Yu XG, Lichterfeld M, Chetty S, Williams KL, Mui SK, Miura T, Frahm N, Feeney ME, Tang Y, Pereyra F et al..  2007.  Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.. J Virol. 81(4):1619-31.
Straub DM, Deeds BGriffin, Willard N, Castor J, Peralta L, Francisco VT, Ellen J.  2007.  Partnership selection and formation: a case study of developing adolescent health community-researcher partnerships in fifteen U.S. communities.. J Adolesc Health. 40(6):489-98.
2008
Deeds BGriffin, Castillo M, Beason Z, Cunningham SD, Ellen JM, Peralta L.  2008.  An HIV prevention protocol reviewed at 15 national sites: how do ethics committees protect communities? J Empir Res Hum Res Ethics. 3(2):77-86.
Deeds BGriffin, Peralta L, Willard N, Ellen J, Straub DM, Castor J.  2008.  The role of community resource assessments in the development of 15 adolescent health community-researcher partnerships.. Prog Community Health Partnersh. 2(1):31-9.
2009
Naar-King S, Parsons JT, Murphy DA, Chen X, D Harris R, Belzer ME.  2009.  Improving health outcomes for youth living with the human immunodeficiency virus: a multisite randomized trial of a motivational intervention targeting multiple risk behaviors.. Arch Pediatr Adolesc Med. 163(12):1092-8.
2010
Dietz E, Clum GA, Chung S-E, Leonard L, Murphy DA, Perez LV, Harper GW, Ellen JM.  2010.  Adherence to scheduled appointments among HIV-infected female youth in five U.S. cities.. J Adolesc Health. 46(3):278-83.
Sill AM, Constantine NT, Wilson CM, Peralta L.  2010.  Demographic profiles of newly acquired HIV infections among adolescents and young adults in the U.S.. J Adolesc Health. 46(1):93-6.
Murphy DA, Lam P, Naar-King S, D Harris R, Parsons JT, Muenz LR.  2010.  Health literacy and antiretroviral adherence among HIV-infected adolescents.. Patient Educ Couns. 79(1):25-9.
Barnes W, D'Angelo L, Yamazaki M, Belzer M, Schroeder S, Palmer-Castor J, Futterman D, Kapogiannis B, Muenz L, D Harris R et al..  2010.  Identification of HIV-infected 12- to 24-year-old men and women in 15 US cities through venue-based testing.. Arch Pediatr Adolesc Med. 164(3):273-6.
Mehta N, Cunningham CK, Flynn P, Pepe J, Obaro S, Kapogiannis BG, Bethel J, Luzuriaga K.  2010.  Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination.. Vaccine. 28(21):3672-8.
Tanney MR, Naar-King S, Murphy DA, Parsons JT, Janisse H.  2010.  Multiple risk behaviors among youth living with human immunodeficiency virus in five U.S. cities.. J Adolesc Health. 46(1):11-6.
Naar-King S, Parsons JT, Murphy D, Kolmodin K, D Harris R.  2010.  A multisite randomized trial of a motivational intervention targeting multiple risks in youth living with HIV: initial effects on motivation, self-efficacy, and depression.. J Adolesc Health. 46(5):422-8.
Outlaw AY, Naar-King S, Janisse H, Parsons JT.  2010.  Predictors of condom use in a multisite study of high-risk youth living with HIV.. AIDS Educ Prev. 22(1):1-14.
Macdonell KE, Naar-King S, Murphy DA, Parsons JT, Harper GW.  2010.  Predictors of medication adherence in high risk youth of color living with HIV.. J Pediatr Psychol. 35(6):593-601.
M Dolcini M, Harper GW, Boyer CB, Pollack LM.  2010.  Project ORE: A friendship-based intervention to prevent HIV/STI in urban African American adolescent females.. Health Educ Behav. 37(1):115-32.
Naar-King S, Kolmodin K, Parsons JT, Murphy D.  2010.  Psychosocial factors and substance use in high-risk youth living with HIV: a multi-site study.. AIDS Care. 22(4):475-82.
2011
Chen X, Murphy DA, Naar-King S, Parsons JT.  2011.  A clinic-based motivational intervention improves condom use among subgroups of youth living with HIV.. J Adolesc Health. 49(2):193-8.
Andrinopoulos K, Clum G, Murphy DA, Harper G, Perez L, Xu J, Cunningham S, Ellen JM.  2011.  Health related quality of life and psychosocial correlates among HIV-infected adolescent and young adult women in the US.. AIDS Educ Prev. 23(4):367-81.
2012
Murphy DA, Chen X, Naar-King S, Parsons JT.  2012.  Alcohol and marijuana use outcomes in the Healthy Choices motivational interviewing intervention for HIV-positive youth.. AIDS Patient Care STDS. 26(2):95-100.
Castillo M, Palmer BJ, Rudy BJ, Fernandez MIsabel.  2012.  Creating partnerships for HIV prevention among YMSM: the Connect Protect® Project and House and Ball Community in Philadelphia.. J Prev Interv Community. 40(2):165-75.
Robles-Schrader GM, Harper GW, Purnell M, Monarrez V, Ellen JM.  2012.  Differential challenges in coalition building among HIV prevention coalitions targeting specific youth populations.. J Prev Interv Community. 40(2):131-48.
Clum GA, Chung S-E, Ellen JM, Perez LV, Murphy DA, Harper GW, Hamvas L.  2012.  Victimization and sexual risk behavior in young, HIV positive women: exploration of mediators.. AIDS Behav. 16(4):999-1010.
Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD et al..  2012.  Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial.. Clin Infect Dis. 54(7):1013-25.
2013
Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2013.  Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 57(11):5619-28.
Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL et al..  2013.  Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein.. Front Genet. 4:234.
Tanner AE, Philbin MM, Ott MA, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2013.  Linking HIV+ adolescents into care: The effects of relationships between local health departments and adolescent medicine clinics.. J HIV AIDS Soc Serv. 12(3-4)
Naar-King S, Outlaw AY, Sarr M, Parsons JT, Belzer M, MacDonell K, Tanney M, Ondersma SJ.  2013.  Motivational Enhancement System for Adherence (MESA): pilot randomized trial of a brief computer-delivered prevention intervention for youth initiating antiretroviral treatment.. J Pediatr Psychol. 38(6):638-48.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Nichols SL, Bethel J, Garvie PA, Patton DE, Thornton S, Kapogiannis BG, Ren W, Major-Wilson H, Puga A, Woods SP.  2013.  Neurocognitive functioning in antiretroviral therapy-naïve youth with behaviorally acquired human immunodeficiency virus.. J Adolesc Health. 53(6):763-71.
Bangi A, M Dolcini M, Harper GW, Boyer CB, Pollack LM.  2013.  Psychosocial Outcomes of Sexual Risk Reduction in a Brief Intervention for Urban African American Female Adolescents.. J HIV AIDS Soc Serv. 12(2):146-159.
2014
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Boyer CB, Robles-Schrader GM, Li SX, Miller RL, Korelitz J, Price GN, Torres CMRivera, Chutuape KS, Stines SJ, Straub DM et al..  2014.  A comparison of network-based strategies for screening at-risk Hispanic/Latino adolescents and young adults for undiagnosed asymptomatic HIV infection.. J Adolesc Health. 55(6):765-73.
Lally M, Goldsworthy R, Sarr M, Kahn J, Brown L, Peralta L, Zimet G.  2014.  Evaluation of an intervention among adolescents to reduce preventive misconception in HIV vaccine clinical trials.. J Adolesc Health. 55(2):254-9.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2014.  Factors affecting linkage to care and engagement in care for newly diagnosed HIV-positive adolescents within fifteen adolescent medicine clinics in the United States.. AIDS Behav. 18(8):1501-10.
Ellen JM, Kapogiannis B, J Fortenberry D, Xu J, Willard N, Duval A, Pace J, Loeb J, Monte D, Bethel J.  2014.  HIV viral load levels and CD4+ cell counts of youth in 14 cities.. AIDS. 28(8):1213-9.
Outlaw AY, Naar-King S, Tanney M, Belzer ME, Aagenes A, Parsons JT, Merlo LJ.  2014.  The initial feasibility of a computer-based motivational intervention for adherence for youth newly recommended to start antiretroviral treatment.. AIDS Care. 26(1):130-5.
Philbin MM, Tanner AE, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  Linking HIV-positive adolescents to care in 15 different clinics across the United States: creating solutions to address structural barriers for linkage to care.. AIDS Care. 26(1):12-9.
Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR et al..  2014.  Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate.. Antivir Ther. 19(6):613-8.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2014.  "Youth friendly" clinics: considerations for linking and engaging HIV-infected adolescents into care.. AIDS Care. 26(2):199-205.
2015
Rudy BJ, Kapogiannis BG, Worrell C, Squires K, Bethel J, Li S, Wilson CM, Agwu A, Emmanuel P, Price G et al..  2015.  Immune Reconstitution but Persistent Activation After 48 Weeks of Antiretroviral Therapy in Youth With Pre-Therapy CD4 >350 in ATN 061.. J Acquir Immune Defic Syndr. 69(1):52-60.
2016
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Nichols SL, Bethel J, Kapogiannis BG, Li T, Woods SP, E Patton D, Ren W, Thornton SE, Major-Wilson HO, Puga AM et al..  2016.  Antiretroviral treatment initiation does not differentially alter neurocognitive functioning over time in youth with behaviorally acquired HIV.. J Neurovirol. 22(2):218-30.
Savel C, Mierzwa S, Gorbach PM, Souidi S, Lally M, Zimet G, Interventions A.  2016.  Avatar Web-Based Self-Report Survey System Technology for Public Health Research: Technical Outcome Results and Lessons Learned.. Online J Public Health Inform. 8(2):e189.
Cherenack EM, Wilson PA, Kreuzman AM, Price GN.  2016.  The Feasibility and Acceptability of Using Technology-Based Daily Diaries with HIV-Infected Young Men Who have Sex with Men: A Comparison of Internet and Voice Modalities.. AIDS Behav. 20(8):1744-53.
Philbin MM, Tanner AE, Duval A, Ellen JM, Xu J, Kapogiannis B, Bethel J, J Fortenberry D.  2016.  HIV Testing, Care Referral, and Linkage to Care Intervals Affect Time to Engagement in Care for Newly Diagnosed HIV-Infected Adolescents in 15 Adolescent Medicine Clinics in the United States.. J Acquir Immune Defic Syndr. 72(2):222-9.
Tanner AE, Philbin MM, Duval A, Ellen J, Kapogiannis B, J Fortenberry D.  2016.  Transitioning HIV-Positive Adolescents to Adult Care: Lessons Learned From Twelve Adolescent Medicine Clinics.. J Pediatr Nurs. 31(5):537-43.
2017
Philbin MM, Tanner AE, Ma A, Chambers BD, Ware S, Kinnard EN, Hussen SA, Lee S, J Fortenberry D.  2017.  Adolescent and Adult HIV Providers' Definitions of HIV-Infected Youths' Successful Transition to Adult Care in the United States.. AIDS Patient Care STDS. 31(10):421-427.
Tanner AE, Philbin MM, Ma A, Chambers BD, Nichols S, Lee S, J Fortenberry D.  2017.  Adolescent to Adult HIV Health Care Transition From the Perspective of Adult Providers in the United States.. J Adolesc Health. 61(4):434-439.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N et al..  2017.  Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis.. Clin Infect Dis. 64(3):317-325.
Philbin MM, Tanner AE, Chambers BD, Ma A, Ware S, Lee S, J Fortenberry D.  2017.  Transitioning HIV-infected adolescents to adult care at 14 clinics across the United States: using adolescent and adult providers' insights to create multi-level solutions to address transition barriers.. AIDS Care. 29(10):1227-1234.
Philbin MM, Tanner AE, Duval A, Ellen JM, Kapogiannis B, J Fortenberry D.  2017.  Understanding Care Linkage and Engagement Across 15 Adolescent Clinics: Provider Perspectives and Implications for Newly HIV-Infected Youth.. AIDS Educ Prev. 29(2):93-104.
2018
Belzer ME, MacDonell KKolmodin, Ghosh S, Naar S, McAvoy-Banerjea J, Gurung S, Cain D, Fan CA, Parsons JT.  2018.  Adaptive Antiretroviral Therapy Adherence Interventions for Youth Living With HIV Through Text Message and Cell Phone Support With and Without Incentives: Protocol for a Sequential Multiple Assignment Randomized Trial (SMART).. JMIR Res Protoc. 7(12):e11183.
Philbin MM, Kinnard EN, Tanner AE, Ware S, Chambers BD, Ma A, J Fortenberry D.  2018.  The Association between Incarceration and Transactional Sex among HIV-infected Young Men Who Have Sex with Men in the United States.. J Urban Health. 95(4):576-583.
Tanner AE, Philbin MM, Chambers BD, Ma A, Hussen S, Ware S, Lee S, J Fortenberry D.  2018.  Healthcare Transition for Youth Living With HIV: Outcomes from a Prospective Multi-site Study.. J Adolesc Health. 63(2):157-165.
Kahn JA, Lee J, Belzer M, Palefsky JM.  2018.  HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination.. AIDS Behav. 22(6):1826-1834.
Baker Z, Javanbakht M, Mierzwa S, Pavel C, Lally M, Zimet G, Gorbach P.  2018.  Predictors of Over-Reporting HIV Pre-exposure Prophylaxis (PrEP) Adherence Among Young Men Who Have Sex With Men (YMSM) in Self-Reported Versus Biomarker Data.. AIDS Behav. 22(4):1174-1183.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2018.  The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.. J Acquir Immune Defic Syndr.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2018.  The role of socio-behavioral factors in sub-protective tenofovir diphosphate (TFV-DP) levels among YMSM enrolled in two PrEP trials.. J Acquir Immune Defic Syndr.
Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB.  2018.  Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone.. Antivir Ther. 23(7):623-628.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, D Harris R et al..  2018.  Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.. Clin Infect Dis. 66(2):220-228.
Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, D Harris R et al..  2018.  Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial.. Clin Infect Dis. 66(2):220-228.
2019
Starks TJ, Ewing SWFeldstei, Lovejoy T, Gurung S, Cain D, Fan CA, Naar S, Parsons JT.  2019.  Adolescent Male Couples-Based HIV Testing Intervention (We Test): Protocol for a Type 1, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11186.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2019.  Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.. J Acquir Immune Defic Syndr. 80(2):160-165.
Arrington-Sanders R, Wilson CM, Perumean-Chaney SE, Patki A, Hosek S.  2019.  Brief Report: Role of Sociobehavioral Factors in Subprotective TFV-DP Levels Among YMSM Enrolled in 2 PrEP Trials.. J Acquir Immune Defic Syndr. 80(2):160-165.
Pennar AL, Dark T, Simpson KN, Gurung S, Cain D, Fan C, Parsons JT, Naar S.  2019.  Cascade Monitoring in Multidisciplinary Adolescent HIV Care Settings: Protocol for Utilizing Electronic Health Records.. JMIR Res Protoc. 8(5):e11185.
Pennar AL, Dark T, Simpson KN, Gurung S, Cain D, Fan C, Parsons JT, Naar S.  2019.  Cascade Monitoring in Multidisciplinary Adolescent HIV Care Settings: Protocol for Utilizing Electronic Health Records.. JMIR Res Protoc. 8(5):e11185.
Parsons JT, Starks T, Gurung S, Cain D, Marmo J, Naar S.  2019.  Clinic-Based Delivery of the Young Men's Health Project (YMHP) Targeting HIV Risk Reduction and Substance Use Among Young Men Who Have Sex with Men: Protocol for a Type 2, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(5):e11184.
Carcone AIdalski, Coyle K, Gurung S, Cain D, Dilones RE, Jadwin-Cakmak L, Parsons JT, Naar S.  2019.  Implementation Science Research Examining the Integration of Evidence-Based Practices Into HIV Prevention and Clinical Care: Protocol for a Mixed-Methods Study Using the Exploration, Preparation, Implementation, and Sustainment (EPIS) Model.. JMIR Res Protoc. 8(5):e11202.
Neilan AM, Patel K, Agwu AL, Bassett IV, K Amico R, Crespi CM, Gaur AH, Horvath KJ, Powers KA, H Rendina J et al..  2019.  Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).. JMIR Res Protoc. 8(4):e9898.
Neilan AM, Patel K, Agwu AL, Bassett IV, K Amico R, Crespi CM, Gaur AH, Horvath KJ, Powers KA, H Rendina J et al..  2019.  Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).. JMIR Res Protoc. 8(4):e9898.
Neilan AM, Patel K, Agwu AL, Bassett IV, K Amico R, Crespi CM, Gaur AH, Horvath KJ, Powers KA, H Rendina J et al..  2019.  Model-Based Methods to Translate Adolescent Medicine Trials Network for HIV/AIDS Interventions Findings Into Policy Recommendations: Rationale and Protocol for a Modeling Core (ATN 161).. JMIR Res Protoc. 8(4):e9898.
Biello KB, Psaros C, Krakower DS, Marrow E, Safren SA, Mimiaga MJ, Hightow-Weidman L, Sullivan P, Mayer KH.  2019.  A Pre-Exposure Prophylaxis Adherence Intervention (LifeSteps) for Young Men Who Have Sex With Men: Protocol for a Pilot Randomized Controlled Trial.. JMIR Res Protoc. 8(1):e10661.
Sales JM, Escoffery C, Hussen SA, Haddad LB, Phillips A, Filipowicz T, Sanchez M, McCumber M, Rupp B, Kwiatkowski E et al..  2019.  Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155).. JMIR Res Protoc. 8(6):e12774.
Sales JM, Escoffery C, Hussen SA, Haddad LB, Phillips A, Filipowicz T, Sanchez M, McCumber M, Rupp B, Kwiatkowski E et al..  2019.  Pre-Exposure Prophylaxis Integration into Family Planning Services at Title X Clinics in the Southeastern United States: A Geographically-Targeted Mixed Methods Study (Phase 1 ATN 155).. JMIR Res Protoc. 8(6):e12774.
Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME et al..  2019.  Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.. Papillomavirus Res. 7:52-61.
Kahn JA, Belzer M, Chi X, Lee J, Gaur AH, Mayer K, Martinez J, Futterman DC, Stier EA, Paul ME et al..  2019.  Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men.. Papillomavirus Res. 7:52-61.
Shannon CL, Keizur EM, Fehrenbacher A, Wood-Palmer D, Ramos W, Koussa M, Fournier J, Lee S-J, Patel D, Akabike WN et al..  2019.  Sexually Transmitted Infection Positivity Among Adolescents With or at High-Risk for Human Immunodeficiency Virus Infection in Los Angeles and New Orleans.. Sex Transm Dis. 46(11):737-742.
Naar S, MacDonell K, Chapman JE, Todd L, Gurung S, Cain D, Dilones RE, Parsons JT.  2019.  Testing a Motivational Interviewing Implementation Intervention in Adolescent HIV Clinics: Protocol for a Type 3, Hybrid Implementation-Effectiveness Trial.. JMIR Res Protoc. 8(6):e11200.
Bauermeister JA, Golinkoff JM, Lin WY, Claude KF, Horvath KJ, Dowshen N, Schlupp A, Vickroy WJ, Desir K, Lopez AV et al..  2019.  Testing the Testers: Are Young Men Who Have Sex With Men Receiving Adequate HIV Testing and Counseling Services? J Acquir Immune Defic Syndr. 82 Suppl 2:S133-S141.
Harper GW, Jadwin-Cakmak LA, Popoff E, Campbell BAnne, Granderson R, Wesp LM.  2019.  Transgender and Other Gender-Diverse Youth's Progression Through the HIV Continuum of Care: Socioecological System Barriers.. AIDS Patient Care STDS. 33(1):32-43.
K Amico R, Dunlap A, Dallas R, Lindsey J, Heckman B, Flynn P, Lee S, Horvath K, Goolsby RWest, Hudgens M et al..  2019.  Triggered Escalating Real-Time Adherence Intervention to Promote Rapid HIV Viral Suppression Among Youth Living With HIV Failing Antiretroviral Therapy: Protocol for a Triggered Escalating Real-Time Adherence Intervention.. JMIR Res Protoc. 8(3):e11416.
2020
Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG et al..  2020.  Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.. Clin Infect Dis. 70(4):687-691.
Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG et al..  2020.  Changes in Bone Mass After Discontinuation of Preexposure Prophylaxis With Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113.. Clin Infect Dis. 70(4):687-691.
Starks TJ, MacDonell KKolmodin, Pennar AL, Dinaj-Koci V, Millar BM, Naar S.  2020.  Drug Use Among Adolescents and Young Adults with Unsuppressed HIV Who Use Alcohol: Identifying Patterns of Comorbid Drug Use and Associations with Mental Health.. AIDS Behav.
Chiaramonte D, Miller RLin, Lee KS, Rivera OJSantiago, Acevedo-Polakovich ID, McGirr S, Porter JL, Ellen JM, Boyer CB.  2020.  Gendered Powerlessness in At-Risk Adolescent and Young Women: An Empirical Model. AIDS Care. :1-10.